Mecasermin

CHEBI:CHEBI_747669

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
Mecasermin
rxcui
615882
product_type
DRUG FOR FURTHER PROCESSING
listing_expiration_date
20251231
dosage_form
INJECTION, SOLUTION
route
SUBCUTANEOUS
active_ingredient_strength
40 mg/4mL
marketing_start_date
20060103
marketing_category
DRUG FOR FURTHER PROCESSING
labeler_name
Ipsen Biopharmaceuticals, Inc.
package_marketing_start_date
20060103
product_ndc
15054-1040
spl_id
baca590c-26f5-483a-8f3a-32034ea07300
active_ingredient_name
MECASERMIN
package_ndc
15054-1040-5
package_description
1 VIAL, MULTI-DOSE in 1 CARTON (15054-1040-5) / 4 mL in 1 VIAL, MULTI-DOSE
manufacturer_name
Ipsen Biopharmaceuticals, Inc.
unii
7GR9I2683O
brand_name
Increlex
brand_name_base
Increlex
application_number
BLA021839
spl_set_id
a8b27a1b-a611-4f91-ad22-76d4b390c3ae
upc
0315054104056
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class